Pharmaceutical - Antibiotics and Infectious diseases

Filter

Popular Filters

201 to 210 of 210 results

Inconclusive Ph III results for Pfizer’s Vfend and Eraxis combo in fungal infections

03-10-2011

There was disappointing news for global drugs behemoth Pfizer (NYSE: PFE) last Friday, when the company…

Antibiotics and Infectious diseasesEraxisPfizerPharmaceuticalResearchVfend

More news from EMA/CHMP September meeting

26-09-2011

Following its meetings last week, the European Medicines Agency’s Committee for Medicinal Products…

Anti-viralsAntibiotics and Infectious diseasesAstellas PharmaCelgeneDificidDificlirEuropeEvipleraGilead SciencesOncologyPharmaceuticalRegulationRevlimidUCBVimpat

Astellas get EU approval for Vibativ for nosocomial pneumonia caused by MRSA

15-09-2011

The European Commission has granted marketing authorization for Japanese drug major Astellas’ (TYO:…

Antibiotics and Infectious diseasesAstellas PharmaEuropePharmaceuticalRegulationTheravanceVibativ

Optimer/Cubist’s Dificid poised to challenge Vancocin usage in C. difficile treatment; report

14-09-2011

Less than half of surveyed infectious disease (ID) specialists and only 6% of surveyed internists demonstrated…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidMarkets & MarketingNorth AmericaOptimer PharmaceuticalsPharmaceuticalVancocin

EU launches development and cooperation projects with South Africa, including AIDS and TB

12-09-2011

European Development Commissioner Andris Piebalgs is visiting South Africa from September 13 to 16 to…

Anti-viralsAntibiotics and Infectious diseasesEuropeFinancialHealthcarePharmaceuticalRest of the World

GlaxoSmithKline partners with BARDA to develop new class of antibiotic; amends deal with Anacor

08-09-2011

The US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority…

Anacor PharmaceuticalAntibiotics and Infectious diseasesFinancialGlaxoSmithKlineLicensingPharmaceuticalResearchTropical diseases

Majority of US surveyed MCOs will consider reimbursing novel OPAT agents; report

17-08-2011

According to surveyed physicians in the USA, the use of out-patient parenteral antibiotic therapy (OPAT)…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsForest LaboratoriesIvanzMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalTeflaroTheravanceVibativ

Bayer makes moxifloxacin available to help WHO TB program in China

15-08-2011

Bayer HealthCare, a unit of Germany’s Bayer AG (BAY: DE), has agreed to support the World Health…

Antibiotics and Infectious diseasesAsia-PacificBayerMarkets & MarketingMoxifloxacinPharmaceutical

US FDA warns high-dose of Pfizer’s Diflucan during pregnancy may cause birth defects

07-08-2011

The US Food and Drug Administration has warned that treatment with chronic, high doses (400-800mg/day)…

Antibiotics and Infectious diseasesDiflucanNorth AmericaPfizerPharmaceuticalRegulation

201 to 210 of 210 results

Back to top